Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes

Molecular Psychiatry

Volumn 2, Issue 4, 1997, Pages 322-329

  Eastwood, S L ^a,b   Heffernan, J ^b   Harrison, P J ^a,b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Antipsychotic; Cyclophilin; GAP 43; Growth associated protein; In situ hybridization; Messenger RNA; Neuroleptic; Striatum; Synaptophysin

Indexed keywords

BRAIN PROTEIN; CYCLOPHILIN; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROMODULIN; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DRUG EFFECT; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HOUSEKEEPING GENE; IN SITU HYBRIDIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SYNAPSE; SYNAPTOSOME;

EID: 0030801828     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000238     Document Type: Article

References (80)

1. Muller P, Seeman P. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Life Sci 1977; 21: 1751-1758.
2. Baker GB, Greenshaw AJ. Effects of the long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol 1989; 9: 1-44.
3. Harrison PJ. Neuroleptic effects on neuronal and synaptic structure. In: Barnes TRE (ed). Antipsychotic Drugs and their Side-Effects. Academic Press: London, 1993; pp 99-110.
4. Hyman SE, Nestler EJ. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996; 153: 151-162.
5. MacGibbon GA, Lawlor PA, Bravo R, Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 1994; 23: 21-32.
6. Merchant KM, Dobie DJ, Filloux FM, Totzke M, Aravagiri M, Dorsa DM. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J Pharmacol Exp Therap 1994; 271: 460-471.
7. Kroesen S, Marksteiner J, Mahata SK, Mahata M, Fischer-Colbrie R, Saria A, Kapeller I, Winkler H. Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain. Neuroscience 1995; 69: 881-891.
8. Eastwood SL, Burnet PWJ, Harrison PJ. Striatal synaptophysin expression and haloperidol-induced synaptic plasticity. Neuroreport 1994; 5: 677-680.
9. Eastwood SL, Burnet PWJ, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66: 309-319.
10. Walaas SI, Jahn R, Greengard P. Quantitation of nerve terminal populations: synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum. Synapse 1988; 2: 516-520.
11. Masliah E, Terry RD, Alford M, DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 1990; 38: 837-844.
12. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-580.
13. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R, Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 1994; 174: 67-72.
14. Masliah E, Pagan AM, Terry RD, DeTeresa R, Mallory M, Gage FH. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp Neurol 1991; 113: 131-142.
15. Lynch MA, Voss KL, Rodriguez J, Bliss TVP. Increase in synaptic vesicle proteins accompanies long-term potentiation in the dentate gyrus. Neuroscience 1994; 60: 1-5.
16. Roch J-M, Masliah E, Roch-Levecq A-C, Sundsmo MP, Otero DAC, Veinberg I, Satoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc Natl Acad Sci USA 1994; 91: 7450-7454.
17. Saito S, Kobayashi S, Ohashi Y, Igarishi M, Komiya Y, Ando S. Decreased synaptic density in aged brains and its prevention by rearing under enriched conditions as revealed by synaptophysin contents. J Neurosci Res 1994; 39: 57-62.
18. 1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of synaptophysin immunoreactivity in adult rat brain. Brain Res 1995; 677: 181-192.
19. Benes FM, Paskevich PA, Davidson J, Domesick VB. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 1985; 329: 265-274.
20. Iniguez C, Calle F, Marshall E, Carreres J. Morphological effects of chronic haloperidol administration on the postnatal development of the striatum. Dev Brain Res 1987; 35: 27-34.
21. Ihara Y, Sato M, Otsuki S, Kaiya H, Namba M. Morphological changes in rat striatal boutons after chronic: methamphelamine and haloperidol treatment. Neurosci Res 1986; 3: 403-410.
22. Meshul CK, Casey DE. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 1989; 489: 338-346.
23. Uranova NA, Orlovskaya DD, Apel K, Klintsova AJ, Haselhorst U, Schenk H. Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse 1991; 1: 253-259.
24. Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 1992; 15: 488-500.
25. Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B. Effect of haloperidol and clozapine on the density of 'perforated' synapses in caudate, nucleus accumbens, and medial profrontal cortex. Psychopharmacology 1992; 106: 45-52.
26. See RE, Chapman MA, Meshul CK. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse 1992; 12: 147-154.
27. Roberts RC, Gaither LA, Gao X-M, Kashyap SM, Tamminga CA. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse 1995; 20: 234-243.
28. 5- enkephalin-immunoreactive synaptic boutons in the rat neostriatum after haloperidol decanoate treatment. Eur J Neurosci 1996; 8: 716-726.
29. Benowitz LI, Perrone-Bizzozero NI. The relationship of GAP-43 to the development and plasticity of synaptic connections. Ann NY Acad Sci 1991; 627: 58-74.
30. Gispen WH, Nielander HB, DeGraan PNE, Oestreicher AB, Schrama LH, Schotman P. Role of the growth-associated protein B-50/GAP-43 in neuronal plasticity. Mol Neurobiol 1992; 5: 61-85.
31. Neve RL, Perrone-Rizzozero NI, Kinklestein S, Zwiers H, Bird E, Kurnit DM, Benowitz LI. The neuronal growth-associated protein GAP-43 (B-50, F1): neuronal specificity, developmental regulation and regional distribution of the human and rat mRNAs. Mol Brain Res 1987; 2: 177-183.
32. de la Monte SM, Federoff HJ, Ng S-C, Grabczyk E, Fishman MC. GAP-43 gene expression during development: persistence in a distinctive set of neurons in the mature central nervous system. Dev Brain Res 1989; 46: 161-168.
33. Console-Bram LM, Fitzpatrick-McElligott SG, McElligott JG. Distribution of GAP-43 mRNA in the immature and adult cerebellum: a role for GAP-43 in cerebellar development and nouroplasticity. Dev Brain Res 1996; 95: 97-106.
34. Levin BE, Dunn-Meynell A. Regulation of growth-associated protein 43 (GAP-43) messenger RNA associated with plastic change in the adult rat barrel receptor complex. Mol Brain Res 1993; 18: 59-70.
35. Bendotti C, Pende M, Samanin R. Expression of GAP-43 in the granule cells of rat hippocampus after seizure-induced sprouting of mossy fibres: in situ hybridization and immunocytochemical studies. Eur J Neurosci 1994; 6: 509-515.
36. Castro R, Brito B, Segovia J, Martin-Trujillo JM, Notario V. Prenatal haloperidol induces a selective reduction in the expression of plasticity-related genes in neonate rat forebrain. Mol Brain Res 1994; 26: 74-80.
37. Palacios G, Mengod G, Sarasa M, Bandier J, Palacios JM. De novo synthesis of GAP-43: in situ hybridization histochemistry and light and electron microscopy immunocytochemical studies in regenerating neurons of cranial nerve nuclei in the rat brain. Mol Brain Res 1994; 24: 107-117.
38. Coleman PD, Kazee AM, Lapham L, Eskin T, Rogers K. Reduced GAP-43 message levels are associated with increased nourofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease. Neurobiol Aging 1992; 13: 631-639.
39. do la Monte SM, Ng SG, Hsu DW. Aberrant GAP-43 gene expression in Alzheimer's disease. Am J Pathol 1995; 147: 934-946.
40. Hatanpää K, Brady DR, Stoll J, Rapaport SI, Chandrasekaran K. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996; 40: 411-420.
41. Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptid-induced dyskinesias. Synapse 1094; 18: 178-189.
42. Eastwood SL, Story P, Burnet PWJ, Heath P, Harrison PJ. Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. J Psychopharmacol 1994; 8: 196-203.
43. Karns LR, Ng SG, Freeman JA, Fishman MC. Cloning of complementary DNA for GAP-43, a neuronal growth related protein. Science 1987; 236: 597-600.
44. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 1988; 7: 261-267.
45. Porter RHP, Burnet PWJ, Eastwood SL, Harrison PJ. Contrasting effects of electroconvulsive shock on mRNAs encoding the high-affinity kainate receptor subunits (KA1 and KA2) and cyclophilin in the rat. Brain Res 1996; 710: 97-102.
46. Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience; 69: 339-343.
47. Miller M, Urban J, Dorsa D. Quantification of mRNA in discrete cell groups of brain by in situ hybridization histochemistry. In: Conn PM (ed). Methods in Neuroscience, vol. 1, Gene Probes. Academic Press: San Diego, 1989, pp 164-181.
48. Goto S, Korematsu K, Nagahiro S, Ushio Y. Distinct neuronal subset reveals perikaryal immuno-staining for synaptophysin (p38) in the striatum of rats. Acta Neuropathol (Berl) 1993; 86: 302-305.
49. Meberg PJ, Routtenberg A. Selective expression of protein F1/(GAP-43) mRNA in pyramidal but not granule cells of the hippocampus. Neuroscience 1991; 45: 721-733.
50. Yao GL, Kiyama H, Tohyama M. Distribution of GAP-43 (B50/F1) mRNA in the adult rat brain by in situ hybridization using an alkaline phosphatase labeled probe. Mol Brain Res 1993; 18: 1-16.
51. Kruger L, Bendotti C, Rivolta R, Samanin R. Distribution of GAP-43 mRNA in the adult rat brain. J Comp Neurol 1993; 333: 417-434.
52. McKinney M, Kent C. Differential expression of GAP-43 mRNA in adult central cholinergic neuronal populations. Mol Brain Res 1994; 23: 213-220.
53. Augood SJ, Arbuthnott GW, Emson PC. Identified cholinergic neurones in the adult rat brain are enriched in GAP-43 mRNA: a double in situ hybridisation study. J Chem Neuroanat 1995; 9: 17-26.
54. Pakkenberg H, Fog R, Nilakantan B. The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations. Psychopharmacologica (Berl) 1973; 29: 329-336.
55. Nielsen EB, Lyon M. Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats. Psychopharmacology 1978; 59: 85-89.
56. Jeste DV, Lohr JB, Manley M. Study of the neuropathologic changes in the striatnm following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology 1992; 106: 154-160.
57. Benes FM, Paskevich PA, Davidson J, Domesick VB. Synaptic rearrangement in medial prefrontal cortex of haloperidol-treated rats. Brain Res 1985; 329: 265-274.
58. Klintzova AJ, Haselhorst U, Uranova NA, Schenk H, Istomin V. The effects of haloperidol on synaptic plasticity in rat's medial prefrontal cortex. J Hirnforsch 1980; 30: 31-37.
59. Vincent SL, McSparren J, Wang RY, Benes FM. Evidence for ultrastructural changes in cortical axodendritic synapses following long-term treatment with halopuridol or clozapine. Neuropsychopharmacology 1991; 5: 147-155.
60. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-1436.
61. Doraiswamy PM, Tupler LA, Krishnan KRR. Nouroleptic treatment and caudate plasticity. Lancet 1995; 345: 734-735.
62. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet 1995; 344: 1434.
63. Christensen E, Moller JE, Faurbye A. Neuropathological investigation of 28 brains from patients with dyskinesia. Acta Psychiatr Scand 1970; 46: 14-23.
64. Jellinger K. Neuropathologic findings after neuroleptic long-term therapy. In: Roizin L, Shiraki H, Grcevic N (eds). Neurotoxicology. Raven Press: Now York, 1977, pp 25-42.
65. Eastwood SL, Burnet PWJ, McDonald B, Clinton J, Harrison PJ. Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience 1994; 59: 881-892.
66. Meshul CK, Stallbaumer RK, Taylor B, Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res 1994; 648; 181-195.
67. Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B. Coadministration of haloperidol and SCH-23390 prevents the increase in 'perforated' synapses due to either drug alone. Neuropsychopharmacology 1992; 7: 285-293.
68. Freed WJ. Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci Biobehav Rev 1994; 18: 111-120.
69. Calabresi P, Pisani A, Mercuri NB, Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 1996; 19: 19-24.
70. Meshul CK, Buckman J, Allen C, Riggan J, Feller DJ. Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment. Synapse 1996; 22: 350-361.
71. Eastwood SL, Porter RHP, Harrison PJ. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci Lett 1996; 212: 1-4.
72. Bargou RCEF, Leube RE. The synaptophysin-encoding gene in rat and man is specifically transcribed in neuroendocrine cells. Gene 1991; 99: 197-204.
73. Perrone-Bizzozero NI, Cansino VV, Kohn DT. Posttranscriptional regulation of GAP-43 gene expression in PC12 cells through protein kinase C-dependent stabilization of the mRNA. J Cell Biol 1993; 120: 1263-1270.
74. Nishizawa K. NGF-induced stabilization of GAP-43 mRNA is mediated by both 3′-untranslated region and a segment encoding the carboxy-terminus peptide. Biochem Biophys Res Comm 1994; 200: 789-796.
75. Eggen BJL, Brandsma D, Kaasperaitis M, Gispen WH, Schrama LH. Rat B-50 gene transcription and translation. Brain Res 1995; 690: 73-81.
76. Mercugliano M, Saller CF, Salama AI, U'Prichard DC, Chesselet M-F. Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat. Neuropsychopharmacology 1992; 6: 179-187.
77. Burnet PWJ, Chen CPL-H, McGowan S, Franklin M, Harrison PJ. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 1996; 73: 531-540.
78. Meador-Woodruff JH, King RE, Darnask SP, Bovenkerek KA. Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine. Mol Psychiatry 1996; 1: 41-53.
79. See RL, Lynch AM, Sorg BA. Subchronic administration of clozapine, but not haloperidol or metaclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats. Neuroscience 1996; 72: 99-104.
80. Sower AC, Bird ED, Perrone-Bizzozero NI. Increased levels of GAP-43 protein in schizophrenic brain tissue demonstrated by a novel immunodetection method. Mol Chem Neuropath 1995; 24: 1-11.